238 related articles for article (PubMed ID: 19698731)
21. mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat.
Chotechuang N; Azzout-Marniche D; Bos C; Chaumontet C; Gausserès N; Steiler T; Gaudichon C; Tomé D
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1313-23. PubMed ID: 19738034
[TBL] [Abstract][Full Text] [Related]
22. Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass.
Diekmann F; Rovira J; Carreras J; Arellano EM; Bañón-Maneus E; Ramírez-Bajo MJ; Gutiérrez-Dalmau A; Brunet M; Campistol JM
J Am Soc Nephrol; 2007 Oct; 18(10):2653-60. PubMed ID: 17804674
[TBL] [Abstract][Full Text] [Related]
23. The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.
Medendorp K; van Groningen JJ; Vreede L; Hetterschijt L; Brugmans L; van den Hurk WH; van Kessel AG
Exp Cell Res; 2009 Aug; 315(14):2399-409. PubMed ID: 19422821
[TBL] [Abstract][Full Text] [Related]
24. Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.
Böhm A; Aichberger KJ; Mayerhofer M; Herrmann H; Florian S; Krauth MT; Derdak S; Samorapoompichit P; Sonneck K; Vales A; Gleixner KV; Pickl WF; Sperr WR; Valent P
Eur J Clin Invest; 2009 May; 39(5):395-405. PubMed ID: 19320940
[TBL] [Abstract][Full Text] [Related]
25. [Effeet of rapamycin on mTOR and eIF-4E expression in coxsackievirus B3-induced rat myocardial cells].
Chen CY; Sun YN; Yang ZC
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):612-7. PubMed ID: 18667775
[TBL] [Abstract][Full Text] [Related]
26. Aspects of mTOR biology and the use of mTOR inhibitors in non-Hodgkin's lymphoma.
Costa LJ
Cancer Treat Rev; 2007 Feb; 33(1):78-84. PubMed ID: 17161912
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients.
Hickerson RP; Leake D; Pho LN; Leachman SA; Kaspar RL
J Dermatol Sci; 2009 Nov; 56(2):82-8. PubMed ID: 19699613
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of PKHD1 may cause S-phase entry via mTOR signaling pathway.
Zheng R; Wang L; Fan J; Zhou Q
Cell Biol Int; 2009 Sep; 33(9):926-33. PubMed ID: 19524688
[TBL] [Abstract][Full Text] [Related]
29. SIRT1 is required for the effects of rapamycin on high glucose-inducing mesangial cells senescence.
Zhang S; Cai G; Fu B; Feng Z; Ding R; Bai X; Liu W; Zhuo L; Sun L; Liu F; Chen X
Mech Ageing Dev; 2012 Jun; 133(6):387-400. PubMed ID: 22561310
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of p70S6 kinase predicts overall survival in patients with clear margin-resected hepatocellular carcinoma.
Baba HA; Wohlschlaeger J; Cicinnati VR; Hilgard P; Lang H; Sotiropoulos GC; Takeda A; Beckebaum S; Schmitz KJ
Liver Int; 2009 Mar; 29(3):399-405. PubMed ID: 18492014
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy targets the mTOR signaling network in vitro and in vivo.
Weyergang A; Berg K; Kaalhus O; Peng Q; Selbo PK
Mol Pharm; 2009; 6(1):255-64. PubMed ID: 19125612
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia reoxygenation induces premature senescence in neonatal SD rat cardiomyocytes.
Zhang FX; Chen ML; Shan QJ; Zou JG; Chen C; Yang B; Xu DJ; Jin Y; Cao KJ
Acta Pharmacol Sin; 2007 Jan; 28(1):44-51. PubMed ID: 17184581
[TBL] [Abstract][Full Text] [Related]
33. Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities.
Su WC; Liu WL; Cheng CW; Chou YB; Hung KH; Huang WH; Wu CL; Li YT; Shiau AL; Lai MY
FEBS Lett; 2009 Sep; 583(17):2793-8. PubMed ID: 19619545
[TBL] [Abstract][Full Text] [Related]
34. mTOR inhibitor everolimus ameliorates progressive tubular dysfunction in chronic renal failure rats.
Nakagawa S; Masuda S; Nishihara K; Inui K
Biochem Pharmacol; 2010 Jan; 79(1):67-76. PubMed ID: 19660439
[TBL] [Abstract][Full Text] [Related]
35. A putative mitotic checkpoint dependent on mTOR function controls cell proliferation and survival in ovarian granulosa cells.
Yaba A; Bianchi V; Borini A; Johnson J
Reprod Sci; 2008 Feb; 15(2):128-38. PubMed ID: 18276949
[TBL] [Abstract][Full Text] [Related]
36. Targeting mammalian target of rapamycin (mTOR) for health and diseases.
Tsang CK; Qi H; Liu LF; Zheng XF
Drug Discov Today; 2007 Feb; 12(3-4):112-24. PubMed ID: 17275731
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen.
Masuo T; Okamura S; Zhang Y; Mori M
Cancer Lett; 2009 Nov; 285(1):66-72. PubMed ID: 19481339
[TBL] [Abstract][Full Text] [Related]
38. SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway.
Hrzenjak A; Kremser ML; Strohmeier B; Moinfar F; Zatloukal K; Denk H
J Pathol; 2008 Dec; 216(4):495-504. PubMed ID: 18850582
[TBL] [Abstract][Full Text] [Related]
39. mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3.
Busch S; Renaud SJ; Schleussner E; Graham CH; Markert UR
Exp Cell Res; 2009 Jun; 315(10):1724-33. PubMed ID: 19331815
[TBL] [Abstract][Full Text] [Related]
40. Two isomers of HDTIC isolated from Astragali Radix decrease the expression of p16 in 2BS cells.
Wang PC; Zhang ZY; Zhang J; Tong TJ
Chin Med J (Engl); 2008 Feb; 121(3):231-5. PubMed ID: 18298915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
